Matches in Nanopublications for { ?s ?p "Clinical treatment of type 2 diabetes with the antihyperglycemic drugs pentoxifylline and metformin restores insulin sensitivity and decreases NPP1 expression [58,173]." ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- _3 value "Clinical treatment of type 2 diabetes with the antihyperglycemic drugs pentoxifylline and metformin restores insulin sensitivity and decreases NPP1 expression [58,173]." provenance.
- _2 value "Clinical treatment of type 2 diabetes with the antihyperglycemic drugs pentoxifylline and metformin restores insulin sensitivity and decreases NPP1 expression [58,173]." provenance.
- _3 value "Clinical treatment of type 2 diabetes with the antihyperglycemic drugs pentoxifylline and metformin restores insulin sensitivity and decreases NPP1 expression [58,173]." provenance.
- _2 value "Clinical treatment of type 2 diabetes with the antihyperglycemic drugs pentoxifylline and metformin restores insulin sensitivity and decreases NPP1 expression [58,173]." provenance.
- _2 value "Clinical treatment of type 2 diabetes with the antihyperglycemic drugs pentoxifylline and metformin restores insulin sensitivity and decreases NPP1 expression [58,173]." provenance.
- _3 value "Clinical treatment of type 2 diabetes with the antihyperglycemic drugs pentoxifylline and metformin restores insulin sensitivity and decreases NPP1 expression [58,173]." provenance.
- _3 value "Clinical treatment of type 2 diabetes with the antihyperglycemic drugs pentoxifylline and metformin restores insulin sensitivity and decreases NPP1 expression [58,173]." provenance.
- _2 value "Clinical treatment of type 2 diabetes with the antihyperglycemic drugs pentoxifylline and metformin restores insulin sensitivity and decreases NPP1 expression [58,173]." provenance.